---
$id: https://graph.org.ai/products/commodity/51434005
$type: Product
source: UNSPSC
code: "51434005"
title: "Vernakalant"
class: "51434000"
classTitle: "Antihypertensive pyrrolidines"
family: "51430000"
familyTitle: "Antihypertensive drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Vernakalant

**UNSPSC Code**: 51434005
**Class**: [Antihypertensive pyrrolidines](Antihypertensive pyrrolidines.mdx)
**Family**: [Antihypertensive drugs](../Antihypertensive drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a mixed ion channel blocker with the molecular formula C20H31NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9G468C8B13, chemically known as (3R)-1-[(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]pyrrolidin-3-ol but generally known as vernakalant, which bears US NIH Compound Identifier 9930049. Vernakalant most often comes in base and hydrochloride forms. European Medicines Agency schedules Vernakalant in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB30707. The term VERNAKALANT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21, No. 3, 2007, List 58). World Health Organization schedules Vernakalant in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, VERNAKALANT remains the US FDA Preferred Term for this commodity. SMILES: COC1=C(C=C(C=C1)CCOC2CCCCC2N3CCC(C3)O)OC.

